Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | GFER | P55789 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.39 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.39 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | NSD2 | O96028 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2906295 | 0.84 | THRB (0.42) | MAPTTDP1KDM4EATML3MBTL1 | |
| SCHEMBL8646552 | 0.83 | THRB (0.47) | MAPTTDP1KDM4EATML3MBTL1 | |
| SCHEMBL10025073 | 0.83 | MAPT (0.46) | MAPTTDP1KDM4EATML3MBTL1 | |
| SCHEMBL2900757 | 0.81 | TDP1 (0.43) | MAPTTDP1KDM4EATML3MBTL1 | |
| SCHEMBL6895096 | 0.81 | MAPT (0.44) | MAPTTDP1KDM4EATML3MBTL1 | |
| SCHEMBL322125 | 0.81 | MAPT (0.44) | MAPTTDP1KDM4EATML3MBTL1 | |
| SCHEMBL10025075 | 0.81 | MAPT (0.44) | MAPTTDP1KDM4EATML3MBTL1 | |
| Ethylene SCHEMBL23748028 | 0.80 | MAPT (0.41) | MAPTTDP1KDM4EATML3MBTL1 | |
| Ethylene SCHEMBL2021059 | 0.80 | TDP1 (0.50) | MAPTTDP1KDM4EATML3MBTL1 | |
| SCHEMBL18073 | 0.79 | TDP1 (0.54) | MAPTTDP1KDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 304 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5283326-A | Coupling azo and cyanine dyes; colorfastness, heat resistance | SANDOZ AG (CH) | 1994-02-01 | — | — | US | claimed |
| US-4837269-A | FIBER-REACTIVE DISAZO DYES | BASF AKTIENGESELLSCHAFT (DE) | 1989-06-06 | — | — | US | claimed |
| US-4751288-A | COLORFASTNESS | BASF AKTIENGESELLSCHAFT (DE) | 1988-06-14 | — | — | US | claimed |
| US-4619992-A | IMPROVED COLORFASTNESS | BASF AKTIENGESELLSCHAFT (DE) | 1986-10-28 | — | — | US | claimed |
| US-4560751-A | CYCLIZATION OF AMIDO-THIOAMIDE COMPOUND | BASF AKTIENGESELLSCHAFT (DE) | 1985-12-24 | — | — | US | claimed |
| US-4496480-A | Isothiazolazo dyes having coupling components which are free from unsaturated aliphatic radicals | BASF AKTIENGESELLSCHAFT (DE) | 1985-01-29 | — | — | US | claimed |
| US-4250090-A | COLORFASTNESS; WETFASTNESS; ACID AZO DYES | BASF AKTIENGESELLSCHAFT (DE) | 1981-02-10 | — | — | US | claimed |
| US-12023316-B2 | FAP-activated therapeutic agents, and uses related thereto | BACH BIOSCIENCES, LLC (US) | 2024-07-02 | — | — | US | disclosed |
| CN-113967258-B | FAP-activated therapeutic agents and related uses | 塔夫茨大学信托人 | 2024-07-02 | — | — | CN | disclosed |
| CN-118109069-A | Resin composition, cured product, and method for producing cured product | 东京应化工业株式会社 | 2024-05-31 | — | — | CN | disclosed |
| CN-118108899-A | Curable resin composition, cured product, and method for producing cured product | 东京应化工业株式会社 | 2024-05-31 | — | — | CN | disclosed |
| US-11925655-B2 | FAP-activated therapeutic agents, and uses related thereto | BACH BIOSCIENCES, LLC (US) | 2024-03-12 | — | — | US | disclosed |
| EP-4299134-A2 | FAP-ACTIVATED THERAPEUTIC AGENTS, AND USES RELATED THERETO | Bach Biosciences, LLC (US) | 2024-01-03 | — | — | EP | disclosed |
| EP-0034716-A1 | Navy blue dyestuff mixtures and their use in dyeing polyesters | BASF Aktiengesellschaft (DE) | 1981-09-02 | — | — | EP | disclosed |
| US-4283331-A | FIBER-REACTIVE DYES | CIBA-GEIGY CORPORATION (US) | 1981-08-11 | — | — | US | disclosed |
| US-4250090-A | COLORFASTNESS; WETFASTNESS; ACID AZO DYES | BASF AKTIENGESELLSCHAFT (DE) | 1981-02-10 | — | — | US | disclosed |
| US-4243809-A | 5-SULFONYL-6-HYDROXYPYRIDONES OR THE 3-CARBAMOYL DERIVATIVES; SULFONYLATION WITH AN ALKYL SULFONYL HALIDE | CIBA-GEIGY CORPORATION (US) | 1981-01-06 | — | — | US | disclosed |
| US-4234482-A | Substituted 3-carbalkoxy 4-alkylamino-azobenzene compound as disperse dyestuffs for synthetic fibers | PRODUITS CHIMIQUES UGINE KUHLMANN SERVICE PROPRIETE INDUSTRIELLE (FR) | 1980-11-18 | — | — | US | disclosed |
| US-4207233-A | Azo dyes containing a thiazole component | BASF AKTIENGESELLSCHAFT (DE) | 1980-06-10 | — | — | US | disclosed |
| US-4180503-A | FOR DYEING POLYAMIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1979-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12023316-B2 | FAP-activated therapeutic agents, and uses related thereto | FAP, FIBP, GOT1 | MAPT 3925/4885TDP1 322/4885KDM4E 2409/4885 |
| US-11925655-B2 | FAP-activated therapeutic agents, and uses related thereto | FAP, FIBP, GOT1 | MAPT 3856/4885TDP1 834/4885KDM4E 2044/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.